Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.065 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |